key: cord-1040299-67l2cnsm authors: Sharma, Nilesh Kumar; Sarode, Sachin; Sarode, Gargi title: Natural vaccines accumulated in facemasks during COVID-19: Underappreciated role of facial masking date: 2021-10-13 journal: J Oral Biol Craniofac Res DOI: 10.1016/j.jobcr.2021.10.001 sha: e51df587d572ade35c74763e56c2a782c0a87b63 doc_id: 1040299 cord_uid: 67l2cnsm Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causal agent behind coronavirus disease 2019 (COVID-19). Despite promising developments in therapeutic and preventive avenues, the importance of facial masking is a key factor for the protective measures among exposed human populations. Preclinical and clinical data on the importance of facial masking concerning asymptomatic over symptomatic COVID-19 cases is limited. Recent introduction of concept on SARS-CoV-2 associated molecular particle patterns (SAMPPs) as a nature vaccine has opened new avenues for comprehensive development of immunity. To take this further, the scope of natural vaccines accumulated in facemasks during facial masking needs to be highlighted that may directly or indirectly contribute to build adaptive immunity among human populations. This paper attempts to discuss the underappreciated contributions of facial masking in the management of COVID-19 at the global level. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused coronavirus disease 2019 to unleash a devastating impact in society. 1, 2 Several reports have addressed the pathogenesis and preventive aspects of COVID-19. [3] [4] [5] The impact of universal facial masking is discussed in the context of infectivity and severity of COVID-19. Several explanations are proposed on the linking of facial masking with adaptive immunity and increasing cases of asymptomatic patients. [6] [7] [8] [9] [10] However, preclinical and clinical experimental evidence is not substantial. In the pursuit of the same, we attempted to propose a novel conceptual design based on the usage of face mask and development of adaptive immunity to support the aforementioned outcomes of the facial masking in general population. Universal facial masking was adapted all over the world to mitigate the spread of SARS-CoV-2, Gandhi et al. 9 take this opportunity to hypothesized the impact of universal face masking with the potential generation of adaptive immunity among exposed human populations due to minimal exposure of infectious components of SARS-CoV-2. There is a lack of direct clinical and biochemical evidence related to such claims. The authors also proposed scientific explanations on the possibilities of natural vaccines in the form SARS-CoV-2 associated molecular particle patterns on the inanimate surfaces, face masks, and other potential physical surfaces during sanitization using alcohol and detergents including anionic, cationic and nonionic, and zwitterionic. 10-12 Alcohol-based hand sanitizers contains 60-95% ethanol, isopropanol, or n-propanol, glycerol 1.45% v/v, hydrogen peroxide (H2O2) 0.125% v/v. Alcohol-free hand sanitizers comprise of disinfectants such as benzalkonium chloride (BAC) and triclosan). [11] [12] [13] [14] [15] Liquid-hand wash includes chemicals such as surfactants (sodium palmate, sodium lauryl sulfate (SLS), betaines, amides, triclosan), pH adjuster (citric acid, KOH, NaOH), viscosity enhancers (sodium chloride, carbomers, polymers), and preservatives (phenoxyethanol, benzyl alcohol, isothiazolinone). Laundry detergents contain anionic surfactants (alkylbenzene sulfonates), non-ionic detergents (polyoxyethylene, glycoside, glycolic acid), and enzymes (protease, amylase, and lipase). [13] [14] [15] J o u r n a l P r e -p r o o f Chemical compositions of various sanitizers, detergents, hand wash, and surfactants are suggested to show direct or indirect denaturing effects upon the RNA components of SARS-CoV-2. [15] [16] [17] The chemical stability of SARS-CoV-2 biological components such as RNA and lipid is reduced by variations in environmental conditions including sanitization, disinfectants, and use of detergents during washing. [18] [19] [20] [21] [22] [23] [24] [25] Conversely, the SPIKE-2 glycoprotein shows appreciable stability such environmental exposures. [22] [23] [24] [25] Experimental data support that the routine uses of sanitizers, disinfectants, and detergents may efficiently denture lipid layer and alkaline labile RNAs components of SARS-CoV-2. 15-25 A proposition is made that the SPIKE-2 glycoprotein remains to an extent stable that enables as potential antigenic components to develop adaptive immunity. [21] [22] [23] [24] [25] An intriguing question is raised to know how many SARS-CoV-2 particles are created in our environment and fractions of that are in the forms of natural vaccines accumulated in masks. A proposition on natural vaccines accumulated in masks are supported by existing understanding that shedding and secretion of SARS-CoV-2 infected patients are predominantly through facial structures including nasal and mouth covered by face masks. Here, a proposed model on natural vaccines accumulated in masks as a potential reason behind developed adaptive immunity and the reduced severity and mortality by SARS-CoV-2 is presented ( Figure 1 ). Additionally, a model without masks and high severity and mortality among COVID-19 patients is depicted ( Figure 2 ). There is a significant shift in the percentage of asymptomatic COVID-19 patients from 40% to more than 80%. [25] [26] [27] The contribution of SARS-CoV-2 associated molecular particle patterns or facial masking is suggested as an indirect factor towards the generation of adaptive immunity in the human populations against SARS-CoV-2. Therefore, high asymptomatic/presymptomatic cases over symptomatic cases and decrease in mortality rate may be indirectly attributed to facial masking practiced among human populations. Epidemiological data would be interesting to see the correlation on uses of facial masking with the proper guidelines and impacts of severity and J o u r n a l P r e -p r o o f mortality due to COVID-19. Altogether, the contribution of natural vaccines accumulated in face masks is the need of the time to be highlighted at preclinical, clinical, and society at large. This will serve as an additional factor towards the sensitization on the uses of facial masking and an indirect role in the prevention of COVID-19. The authors agree that there is a lack of direct clinical data on natural vaccines accumulated in face masks and the severity of COVID-19. In the future, a study may be designed to answer a pertinent question that may help to estimate the impact of different styles and designs of face masks on the proposed existence of natural vaccines accumulated in face masks. The best study model in this regard would be animal face masking in a controlled environment infested with SARS-CoV-2 and its accumulated particles. Furthermore, natural vaccines accumulated in face masks among the SARS-CoV-2 exposed human populations may be impacted by the social behaviors and individual habits such as frequency of touching of facial structures. In summary, we propose for a discussion in a larger perspective across the globe by preclinical, clinical, and epidemiologists to see the prospects of use of masks that may contribute towards minimal exposure of infectious components of SARS-CoV-2 and natural vaccines accumulated in masks that may help for the development of potential adaptive immunity among exposed human populations. This will provide new dimension to the various attributes of facial masking and would also be applicable to the future viral pandemics as well. Moreover, this paper will also help in providing befitting reply to the facial mask hesitancy among the general population. All the authors associated with present manuscript declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. J o u r n a l P r e -p r o o f Covid-19 -Navigating the Uncharted Clinical characteristics of coronavirus disease 2019 in China How does SARS-CoV-2 cause COVID-19? Cell entry mechanisms of SARS-CoV-2 Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes A perspective on potential antibody-dependent enhancement of SARS-CoV-2 Extrapulmonary manifestations of COVID-19 Facial Masking for Covid-19 -Potential for "Variolation" as We Await a Vaccine Triton X-100 concentration effects on membrane permeability of a single HeLa cell by scanning electrochemical microscopy (SECM) The mechanism of detergent solubilization of lipid bilayers Alcohol-based hand sanitisers as first line of defence against SARS-CoV-2: a review of biology, chemistry and formulations Hand sanitisers amid CoViD-19: A critical review of alcohol-based products on the market and formulation approaches to respond to increasing demand The evolution of anionic surfactant technology to meet the requirements of the laundry detergent industry The Mechanism of the Alkaline Hydrolysis of Ribonucleic Acids Origin of life--facing up to the physical setting Kinetics and mechanisms for the cleavage and isomerization of the phosphodiester bonds of RNA by Brønsted acids and bases Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications Alkaline hydrolysis to remove potentially infectious viral RNA contaminants from DNA Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37 degrees C correlates with virus aggregation and virus-induced cell fusion On the pH-optimum of activity and stability of proteins Modulation of the pH Stability of Influenza Virus Hemagglutinin: A Host Cell Adaptation Strategy Physicochemical properties of SARS-CoV-2 for drug targeting, virus inactivation and attenuation, vaccine formulation and quality control Methods of Inactivation of SARS-CoV-2 for Downstream Biological Assays Descriptive epidemiology of SARS-CoV-2 infection in Karnataka state, South India: Transmission dynamics of symptomatic vs. asymptomatic infections The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects